Sakar Healthcare reported a 120.13% YoY surge in Q1 FY27 net profit to ₹10.28 crore, while revenue from operations grew 38.39% to ₹72.97 crore. EBITDA increased by 67.32% with the margin expanding to 29%. The company executed over 65 oncology contracts, advanced regulatory filings, and strengthened its in-house oncology API capabilities during the quarter.